Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
PreVent
1 other identifier
interventional
401
1 country
5
Brief Summary
Complications are common during endotracheal intubation of critically ill adults. Manual ventilation between induction and intubation ("bag-valve-mask" ventilation) has been proposed as a means of preventing hypoxemia, the most common complication of intubation outside the operating room. Safety and efficacy data, however, are lacking. PreVent is a randomized trial comparing manual ventilation between induction and laryngoscopy to no manual ventilation between induction an laryngoscopy during endotracheal intubation of critically ill adults. The primary efficacy endpoint will be the lowest arterial oxygen saturation. The primary safety endpoints will be the lowest oxygen saturation, highest fraction of inspired oxygen, and highest positive end-expiratory pressure in the 24 hours after the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2017
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2017
CompletedFirst Posted
Study publicly available on registry
January 20, 2017
CompletedStudy Start
First participant enrolled
March 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 6, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 6, 2018
CompletedSeptember 13, 2018
September 1, 2018
1.1 years
January 16, 2017
September 12, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Lowest arterial oxygen saturation
The lowest arterial oxygen saturation measured by continuous pulse oximetry (SpO2) between induction and 2 minutes after completion of the airway management procedure.
Induction to 2 minutes after completion of the airway management procedure
Secondary Outcomes (26)
Incidence of lowest oxygen saturation less than 90%
Induction to 2 minutes after completion of the airway management procedure
Incidence of lowest oxygen saturation less than 80%
Induction to 2 minutes after completion of the airway management procedure
Change in saturation from induction to lowest oxygen saturation
Induction to 2 minutes after completion of the airway management procedure
Incidence of desaturation
Induction to 2 minutes after completion of the airway management procedure
Lowest oxygen saturation in the 24 hours after intubation.
24 hours after intubation
- +21 more secondary outcomes
Study Arms (2)
Manual Ventilation
ACTIVE COMPARATORBeginning after the administration of sedation/neuromuscular blockade, manual ventilation will be provided by bag-valve-mask until the initiation of laryngoscopy. In patients requiring more than one attempt at laryngoscopy, bag-valve-mask ventilation will resume between laryngoscopy attempts.
No Manual Ventilation
ACTIVE COMPARATORBetween the administration of sedation/neuromuscular blockade and intubation, ventilation will not be provided unless the patient experiences an arterial oxygen saturation less than 90%. For patients who experience an oxygen saturation less than 90% after induction, bag-valve-mask ventilation may be provided.
Interventions
Beginning after the administration of sedation/neuromuscular blockade, manual ventilation will be provided by bag-valve-mask until the initiation of laryngoscopy. In patients requiring more than one attempt at laryngoscopy, bag-valve-mask ventilation will resume between laryngoscopy attempts.
Between the administration of sedation/neuromuscular blockade and intubation, ventilation will not be provided unless the patient experiences an arterial oxygen saturation less than 90%. For patients who experience an oxygen saturation less than 90% after induction, bag-valve-mask ventilation may be provided.
Eligibility Criteria
You may qualify if:
- Patient is located in a participating unit
- Planned procedure is endotracheal intubation
- Planned operator is a provider expected to routinely perform endotracheal intubation in the participating unit
- Administration of sedation and/or neuromuscular blockade is planned
- Age ≥ 18 years old
You may not qualify if:
- Urgency of intubation precludes safe performance of study procedures
- Operator feels a specific approach to ventilation between induction and intubation is required
- Pregnant women
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
The University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Louisiana State University School of Medicine
New Orleans, Louisiana, 70112, United States
Ochsner Health System
New Orleans, Louisiana, 70121, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37209, United States
Harborview Medical Center, University of Washington
Seattle, Washington, 98104, United States
Related Publications (2)
Casey JD, Janz DR, Russell DW, Vonderhaar DJ, Joffe AM, Dischert KM, Brown RM, Zouk AN, Gulati S, Heideman BE, Lester MG, Toporek AH, Bentov I, Self WH, Rice TW, Semler MW; PreVent Investigators and the Pragmatic Critical Care Research Group. Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults. N Engl J Med. 2019 Feb 28;380(9):811-821. doi: 10.1056/NEJMoa1812405. Epub 2019 Feb 18.
PMID: 30779528DERIVEDCasey JD, Janz DR, Russell DW, Vonderhaar DJ, Joffe AM, Dischert KM, Brown RM, Lester MG, Zouk AN, Gulati S, Stigler WS, Rice TW, Semler MW; PreVent Investigators and the Pragmatic Critical Care Research Group. Manual ventilation to prevent hypoxaemia during endotracheal intubation of critically ill adults: protocol and statistical analysis plan for a multicentre randomised trial. BMJ Open. 2018 Aug 10;8(8):e022139. doi: 10.1136/bmjopen-2018-022139.
PMID: 30099400DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Matthew W Semler, MD, MSc
Vanderbilt University Medical Center
- PRINCIPAL INVESTIGATOR
Todd W Rice, MD, MSc
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Division of Pulmonary and Critical Care Medicine
Study Record Dates
First Submitted
January 16, 2017
First Posted
January 20, 2017
Study Start
March 15, 2017
Primary Completion
May 6, 2018
Study Completion
July 6, 2018
Last Updated
September 13, 2018
Record last verified: 2018-09